Burmester JK - Search Results

1

Gene therapy for cancer treatment: past, present and future.

Cross D, Burmester JK. Cross D, et al. Among authors: burmester jk. Clin Med Res. 2006 Sep;4(3):218-27. doi: 10.3121/cmr.4.3.218. Clin Med Res. 2006. PMID: 16988102 Free PMC article. Review.

2

The promise of molecular profiling for cancer identification and treatment.

Cross D, Burmester JK. Cross D, et al. Among authors: burmester jk. Clin Med Res. 2004 Aug;2(3):147-50. doi: 10.3121/cmr.2.3.147. Clin Med Res. 2004. PMID: 15931350 Free PMC article. Review. No abstract available.

3

Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.

Cross D, Reding DJ, Salzman SA, Zhang KQ, Catalona WJ, Burke J, Burmester JK. Cross D, et al. Among authors: burmester jk. Med Oncol. 2004;21(2):145-53. doi: 10.1385/MO:21:2:145. Med Oncol. 2004. PMID: 15299187

4

Functional characterization of the HOXB13 promoter region.

Cross DS, Burmester JK. Cross DS, et al. Among authors: burmester jk. Med Oncol. 2008;25(3):287-93. doi: 10.1007/s12032-007-9033-z. Epub 2007 Dec 28. Med Oncol. 2008. PMID: 18163187

5

Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines.

Cross DS, Burmester JK. Cross DS, et al. Among authors: burmester jk. Med Oncol. 2008;25(1):40-9. doi: 10.1007/s12032-007-0038-4. Epub 2007 Jun 27. Med Oncol. 2008. PMID: 18188713

6

A SMAD4 mutation indicative of juvenile polyposis syndrome in a family previously diagnosed with Menetrier's disease.

Burmester JK, Bell LN, Cross D, Meyer P, Yale SH. Burmester JK, et al. Dig Liver Dis. 2016 Oct;48(10):1255-9. doi: 10.1016/j.dld.2016.06.010. Epub 2016 Jun 17. Dig Liver Dis. 2016. PMID: 27375208

7

A genetic approach to the problem of chronic wasting disease in Wisconsin.

Cross D, Burmester JK. Cross D, et al. Among authors: burmester jk. WMJ. 2002;101(8):25-7. WMJ. 2002. PMID: 12557609 No abstract available.

8

Genetics of prostate cancer.

Zhang KQ, Salzman SA, Reding DJ, Suarez BK, Catalona WJ, Burmester JK. Zhang KQ, et al. Among authors: burmester jk. Clin Med Res. 2003 Jan;1(1):21-8. doi: 10.3121/cmr.1.1.21. Clin Med Res. 2003. PMID: 15931281 Free PMC article.

9

Evaluation of genetic factors for warfarin dose prediction.

Caldwell MD, Berg RL, Zhang KQ, Glurich I, Schmelzer JR, Yale SH, Vidaillet HJ, Burmester JK. Caldwell MD, et al. Among authors: burmester jk. Clin Med Res. 2007 Mar;5(1):8-16. doi: 10.3121/cmr.2007.724. Clin Med Res. 2007. PMID: 17456829 Free PMC article.

10

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data.

Hillman MA, Wilke RA, Yale SH, Vidaillet HJ, Caldwell MD, Glurich I, Berg RL, Schmelzer J, Burmester JK. Hillman MA, et al. Among authors: burmester jk. Clin Med Res. 2005 Aug;3(3):137-45. doi: 10.3121/cmr.3.3.137. Clin Med Res. 2005. PMID: 16160068 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page